AKT1 and breast cancer: Furthermore, Xiao Ji demonstrates the capacity to modulate various signaling pathways, encompassing “p53,” “apoptosis,” “HIF-1,” “TNF,” and the “PI3K-Akt” pathway, serving as a potential therapeutic strategy for the management of BC.